Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Methicillin-resistant staphylococcus aureus (MRSA) drugs market is expected to grow at a significant CAGR during the forecast period. Staphylococcus aureus is a bacterium that can be found on healthy people's nose or skin. MRSA, or methicillin-resistant staphylococcus aureus, is a kind of staphylococcus aureus resistant to methicillin, a beta-lactam antibiotic. Methicillin is ineffective against MRSA strains. MRSA infects around 1% of the population who have staphylococcus aureus on their nose or skin. The infection affects the skin and tissues and spreads through direct skin-to-skin contact.
MRSA is spread in two out of
every 100 people, according to the Centers for Disease Control and Prevention
(CDC). In 2020, the number of people who were diagnosed with
methicillin-resistant Staphylococcus aureus (MRSA) for the first time was
significantly lower than in prior years. 2,883 cases were reported in 2020,
compared to 3,657 cases in 2019, 3,669 cases in 2018, 3,579 cases in 2017, and
3,550 cases in 2016. Patients staying in long-term health care institutions for
an extended period of time are a crucial component in the outbreak of MRSA
infections. According to the Healthcare Cost & Utilization Project (HCUP),
a collection of healthcare databases in the US, hospitalized patients are more
likely than non-hospitalized patients who died from MRSA infections (4.7% vs.
2.1% respectively).
Improved detection of antibiotic-resistant bacterium strains
utilizing technologically sophisticated diagnostic methods, as well as an
increase in antibiotic use across the globe, are likely to propel the growth of
the global MRSA antibiotic preparations market. Teixobactin, according to
University of Melbourne experts, is effective against MRSA. These findings are
anticipated to pave the way for the development of antibacterial medications to
treat Gram-positive infections with thick cell walls that are
multidrug-resistant. This will support accelerating the market growth.
To Request a Sample of our Report on Methicillin-Resistant
Staphylococcus Aureus (MRSA) Drugs Market: https://www.omrglobal.com/request-sample/methicillin-resistant-staphylococcus-aureus-mrsa-drugs-market
Market Coverage
•
The market number available for – 2022-2030
•
Base year- 2022
•
Forecast period- 2023-2030
Segment Covered-
·
By Drug Class
·
By Route of Administration
·
By Distribution Channel
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape:
Pfizer Inc., Merck & Co. Inc, and AbbVie Inc. among others.
MRSA Drugs Market Report by Segment
By Drug Class
•
Lipopeptide
•
Oxazolidinone
•
Tetracycline
•
Cephalosporin
•
Lipoglycopeptide
•
Others
By Route of Administration
•
Oral
•
Parenteral
By Distribution Channel
•
Online Pharmacy
•
Hospital Pharmacy
•
Retail Pharmacy
A
full Report of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market is
Available @ https://www.omrglobal.com/industry-reports/methicillin-resistant-staphylococcus-aureus-mrsa-drugs-market
MRSA Drugs Market by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
·
Latin America
·
Middle East and Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/methicillin-resistant-staphylococcus-aureus-mrsa-drugs-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment